logo

For the Inventor, By the Inventor

Tokyo, Japan

Tokuji Okazaki

This inventor holds 1 USPTO granted patent. Top assignee: Ohta Seiyaku Kabushiki Kaisha. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tokuji Okazaki. Retrieved from https://idiyas.com/inventor/tokuji-okazaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 3 
 
Ohta Seiyaku Kabushiki Kaisha
 patents

Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents
1. 4567172 - 6.alpha.-Methylprednisolone derivatives (1986-01-28),

Title: Tokuji Okazaki: Innovator in Anti-inflammatory Drug Development

Introduction

Tokuji Okazaki is a notable inventor based in Tokyo, Japan. He is recognized for his contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory drugs. His innovative work has led to significant advancements in treating various dermal disorders and allergic diseases.

Latest Patents

Okazaki holds a patent for a compound known as 6.alpha.-Methylprednisolone derivatives. This compound is characterized by a general formula that includes specific alkyl and phenyl groups. It exhibits a strong local anti-inflammatory effect, making it useful as a harmless external anti-inflammatory drug. Additionally, it serves as an antiallergic drug for treating asthma and other allergic diseases. His patent is a testament to his commitment to improving healthcare through innovative solutions. He has 1 patent to his name.

Career Highlights

Throughout his career, Tokuji Okazaki has worked with Ohta Seiyaku Kabushiki Kaisha, a company dedicated to pharmaceutical development. His role in the company has allowed him to focus on research and innovation in the field of anti-inflammatory medications. His work has had a lasting impact on the pharmaceutical industry.

Collaborations

Okazaki has collaborated with notable colleagues, including Yoshiaki Kamano and Saburo Sugai. These collaborations have contributed to the advancement of research and development in their respective fields.

Conclusion

Tokuji Okazaki's contributions to the pharmaceutical industry, particularly in the development of anti-inflammatory drugs, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the treatment of various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…